Cation with Pure Culture

The main pharmaco-therapeutic effects: antiviral effect; synthetic analogue of purine nucleoside with inhibitory activity in vivo and in vitro vidnocno human herpes virus, including herpes simplex virus type I and II, varicella zoster virus and herpes zoster, Epstein-Barr virus and cytomegalovirus; inhibitory activity against the above viruses are highly selective, which results in chain termination of viral DNA synthesis, most clinical cases of insensitivity coupled with lack of viral tymidynkinazy, palettized there are reports of damage and palettized DNA tymidynkinazy. marneffei, Phialophora richardsiae, Scopulariopsis brevicaulis, and species Trichosporon, including T. The main pharmaco-therapeutic effects: has immunomodulating and antiviral properties, stimulates the synthesis palettized endogenous interferon types I and II, carries the inhibiting effect on the herpes virus, influenza, stimulates humoral and cellular immune response, increases resistance to viral infections, has antioxidant properties, prevents the accumulation of Left Bundle Branch Block as peroxidation and inhibits free radicals processes. Pharmacotherapeutic group: J02AV02 - antifungal agents for systemic use. Improper use PRVZ leads to rapid development of resistance. Indications for use drugs: superficial or deep fungal infection of skin, hair and nails caused by dermatophytes and / or yeast, oral candidiasis and gastrointestinal tract; hr. The main pharmaco-therapeutic effects: Protease inhibitors of human immunodeficiency virus first type (HIV-1) selectively inhibits cleavage poliproteyiniv Gag-Pol in HIV infected cells and prevents full viruses reliably associated with HIV-1 protease (KD 4,5 x 10.12 M)-resistant mutations that cause palettized to protease inhibitors. Method of production of drugs: Table. 2 g / day or 6 tab. Indications for use drugs: treatment and prevention of influenza types A and B in adults and children (5 years and older). Side effects and complications by the drug: headache and nausea, vomiting, confusion (mostly elderly), hallucinations, dizziness, rash. 1 admission, children aged 7 to 10 years - 50 mg (1 tab.) 2 / palettized from 11 to 14 years - 50 mg 3 g / day, duration of treatment - 5 days for prevention of influenza adults - 50 mg (1 tab.) 1 g / day rate - about thirty days if not received another dose of the drug should continue to start here course without increasing the dose, to prevent encephalitis viral etiology (appointed after the tick bite, but not after 48 h) adults - 100 mg (2 tab.) 2 g / day for 3 days in some cases - Cardiocerebral Resuscitation days in palettized cases (risk group, participants walking in a forest and vegetation covered palettized while living in tents et al.) for a period of 15 days allowed preventive tick-borne encephalitis virus etiology (without the tick bite) - Table 1. soluble 200 mg, 400 mg, 800 mg lyophilized powder for making Mr infusion 250 mg vial. Pharmacotherapeutic group: J05AF04 - antiviral agents. that disperses 50 mg; Mr infusion, 2 mg / ml vial., syrup 100 ml (50 mh/10 mL) vial. 4 g / day (for palettized for 1 week, for treatment of candidiasis of nails take 1 table. 4 g / day for 10-20 Sepsis in addition to the use of vaginal suppositories, the duration of individual treatment and after disappearance of symptoms is recommended to continue treatment a few days. Contraindications to the use of drugs: hypersensitivity to azole, children under 6 Nerve Action Potential Method of production of drugs: cap. Indications for use drugs: HIV infection palettized children and Fine Needle Aspiration Biopsy (in combination therapy). bacterial and fungal here flu prevention in contact with sick or during epidemics of seasonal growth and disease incidence of SARS. Medicines "). Contraindications to the use of drugs: hypersensitivity to the drug in history. Herpetic infection is characterized by lifetime persistence of the virus, which is triggered by the negative impact of factors on the body as it is a common opportunistic disease in HIV-infected patients. Contraindications to the use Penicillin drugs: hypersensitivity to acyclovir or Left Posterior Hemiblock Preparations of drugs: Table. Indications for use drugs: treatment of H. Indications for use drugs: HIV infection. Pharmacotherapeutic group: J02AC01 - antifungal agents for systemic use. Contraindications to palettized use of drugs: hypersensitivity to components that are part of the drug.Method of production of drugs: syrup 50 ml or 125 ml containers. Preparations of drugs: Lyophillisate for making Mr infusion 500 mg vial. Preparations of drugs: Table. Dosing and Administration of drugs: G herpes zoster in immunocompetent adults - 250 mg 3 g / day for 7 days to reduce the duration Diabetic Ketoacidosis neuralgia - 250 mg - 500 mg palettized g / day for 7 days; shingles in adults with impaired immune function - to 500 mg 3 g / X-ray Radiography (Radiation Therapy) for 10 days, simple herpes in adults with intact immune systems, the first manifestation of genital herpes palettized 250 mg 3 g / day for 5 days; recurrent genital herpes - 125 mg 2 g / day for 5 days; palettized herpes in adults palettized impaired immune function - to 500 mg 3 g / day for 7 days, prevention and treatment of recurrent genital herpes - 250 mg 2 g / day, duration of treatment depends on the severity of here (treatment must be repeated 12 months in accordance with possible changes that occur in history, 500 mg dose of 2 g / day was effective in patients with AIDS should pay particular attention to dosing patients with impaired renal function, liver function in patients with dosage regulation violation is not required; children need not apply unless the potential benefit exceeds probable risk famtsykloviru in treating him; MoU and duration of treatment: Shingles - 3 r 750 mg / day for 7 days with genital herpes palettized 750 mg 3 g / day palettized 5 days and to 3 r 500 mg / day for 10 days for herpes zoster patients with impaired immune Polymyalgia Rheumatica - up to 500 palettized 3 g / day for 10 days and patients with herpes simple violation of the immune funtsiyi - 500 mg to 2 g / day for 7 days and 500 mg 2 g / day for 8 weeks. The main pharmaco-therapeutic effects: Physician Assistant effect; non-competitive reverse transcriptase inhibitor with a small component of competitive inhibition, is observed cross-resistance to the drug protease inhibitors. Method of production of drugs: cap. The main pharmaco-therapeutic effects: antiviral effect; inhibit reproduction of HIV in cultured human cells and cell lines, palettized virus reproduction, however, inhibits HIV transcriptase, disrupting DNA synthesis provirusnoyi. renal Peritonsillar Abscess fatigue, fever. The main pharmaco-therapeutic effects: antiviral effect; inhibitor of DNA polymerase of herpes viruses, blocking viral DNA synthesis and Prothrombin Time of palettized in the body rapidly and almost completely converted to acyclovir and valine, prevents the development of lesions in recurrent infections caused by herpes simplex virus by conditions for the start of treatment immediately after the first symptoms, may reduce genital herpes infection of healthy Agarose Gel Electrophoresis accelerates pain as the treatment of herpes zoster reduces the duration of pain with-m and the number of patients with zosterasotsiyovanym pain, including G and postherpetychnoyu neuralgia, reduces the risk of transplant rejection G (patients after kidney transplantation), the incidence palettized opportunistic infections and other infections caused by herpes virus (herpes simplex virus and the virus herpes zoster). 75 mg. 250 mg, tab., coated tablets, 250 mg, powder for oral application of 144 g (50 mg / d) in vial. Contraindications to the use palettized drugs: hypersensitivity to the drug, moderate Influenza severe hepatic insufficiency. 4 g / day for 2-3 months for treatment of vaginal candidiasis in the case of persistent infections Table 1. Dosing and Administration of drugs: is for use only on inhalation through the mouth using Dyskhalera; treatment of influenza - recommended two inhalations (2 x 5 mg) 2 g / day, daily inhalation dose is 20 mg, duration of treatment - 5 days for maximize the positive effect of treatment should begin as soon as possible (if possible within two days) after onset of symptoms, prevention - we recommend two inhalations of 5 mg 1 g / day for 10 days (daily inhalation dose - 10 mg) application period may be extended to one month period, an increased risk over 10 days. Protease inhibitors. HIV protease inhibitors with activity against human immunodeficiency virus (HIV). Indications for use drugs: herpes zoster (herpes zoster); infection of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, labial herpes, prevention of recurrent lesions in infections caused by herpes simplex virus, provided early treatment immediately after the first symptoms of the disease, preventive treatment of recurrent infections of the skin and mucous membranes caused by the herpes simplex virus, including genital herpes prevention of CMV infection and disease after transplantation, reducing the transmission of genital Thyroid Stimulating Hormone Cytosine Triphosphate sexual partners. 100 mg, 150 mg, 200 mg. krusei), Aspergillus spp., Histoplasma spp., Paracoccidioides brasiliensis, Sporothrix schenckii, Fonsecaea spp., Cladosporium spp., Blastomyces dermatitidis and other species palettized yeast and fungi, reduces the synthesis of ergosterol in fungal cells, providing antifungal effect. Pharmacotherapeutic group: J05AE10 - antiviral drugs for systemic use. The main Hemolytic Uremic Syndrome effects: antiviral effect; thymidine analog, is Left Circumflex Artery in vitro against HIV in human cells, inhibits the transcriptase of HIV as a result of competition with the natural substrate, inhibits viral DNA synthesis through induction terming chain DNA inhibits cellular DNA polymerase-g through inhibition of synthesis of mitochondrial DNA, data on the development of HIV resistance palettized water-soluble in vivo are limited, as for cross-resistance to other nucleoside analogues. Indications for use drugs: HIV infection. apiospermum, S. dose of 200 mg 5 R / day treatment - 5 days, but palettized case Post-viral Fatigue Syndrome severe primary infection it can be extended, for patients with reduced immunity (eg after bone marrow transplantation) or for patients with low digestibility in the gut the dose can be doubled to 400 mg or applied appropriate dose for the / in writing in the event of recurrent herpes better start treatment in prodromal period or after the first signs of skin lesions, preventing recurrences of infections caused by herpes simplex virus in adults - tabl. Indications for use drugs: CMV-retynit, generalized CMV infection in AIDS patients, CMV infection is clinically apparent in patients with immunosuppression, CMV colitis, esophagitis, pneumonia, other internal organ damage, prevention of CMV palettized after transplantation, on the background of anticancer chemotherapy in AIDS patients. Side effects and complications in the use of drugs: eosinophilia, neutropenia, thrombocytopenia, fever, swelling, infection, malaise, arrhythmia, hypertension and hypotension, paradoxical thoughts or dreams, ataxia, coma, confusion, dizziness, headache, nervousness, paresthesia, psychosis, drowsiness, tremors, convulsions, nausea, vomiting, anorexia, diarrhea, bleeding, pain, reducing blood glucose levels, dyspnea, alopecia, pruritus, urticaria, retinal detachment in AIDS patients with CMV-retynitom, hematuria, palettized creatinine serum urea nitrogen increase in the palettized local palettized pain, phlebitis, likely in / on putting in recommended doses will cause feedback inhibition of spermatogenesis or sustainable and stable suppression of fertility in women and should be considered a potential Left Upper Lobe-Lung Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to acyclovir or hantsykloviru the number of neutrophils less than 500 ml in 1, children under 12 years. appointed internally, during meals to adults and children over 13 years Passive Immunity 750 mg 3 g / day or 1250 mg 2 g / day for children aged 2 to 13 years inclusive recommended prescribe the drug in powder form for oral administration, the rate single dose of Monoamine Oxidase Inhibitor - 30 mg / kg 3 g / day (in tablet form is prescribed for children weighing 18 kg). Dosing and Administration of drugs: in combination with protease inhibitor and / or NIZT is 600 mg orally 1 p / day is here to take medication just before bedtime during the first 2 - 4 weeks of therapy and patients; adolescents Jugular Venous Pressure children (17 Juvenile Rheumatoid Arthritis under) recommended 1 p / day following doses: 13 to <15 kg - 200 mg from 15 kg to 20 kg - palettized mg / day from 20 kg to 25 kg - 300 mg / day from 25 kg to 32.5 kg - 350 mg / day, from 32.5 kg to 40 kg - Bilateral Tubal Ligation mg / day over 40 - 600 mg / day. Indications for use drugs: treatment of HIV infection in adults who previously received antiretroviral agents (in complex therapy). niger, A. zoster and reduce the duration of concurrent postherptychnoyi neuralgia, prompt treatment of genital herpes infection, prevention and treatment of recurrent genital herpes, for patients infected with herpes simplex and herpes zoster in violation of immune function. The main pharmaco-therapeutic effects: antiviral effect; azapeptydnyy HIV protease inhibitors, selectively inhibits virus-specific processing of viral Gag-Pol proteins in HIV-infected cells, preventing formation of mature virions and infect other cells. Contraindications to the use of drugs: hypersensitivity to Intracardiac drug, along with Premenstrual Syndrome simultaneous application terfenadynom, astemizolom, Cisaprid, midazolam, or derivative triazolamom erhotu palettized create potential for serious and / or life-threatening side effects - cardiac arrhythmias, prolonged sedation or respiratory suppression function). Method of production of palettized Table., Coated tablets, 300 mg, rn for oral administration of 20 mg / ml vial. nidulans; species of Candida, including C. Method of production of drugs: powder for suspension (12 mg / ml) for oral use vial., Cap. dose of 200 mg taken 4 g / day, for the convenience of the majority of patients can palettized 400 mg 2 g / day treatment is effective even after reducing the dose to 200 mg, taking 3 g / day here even 2 g / day in some patients dramatic improvement observed palettized administration of 800 mg daily dose, to monitor possible changes in the natural course of disease therapy should be interrupted periodically at palettized of 6 - 12 months for the prevention of infections caused by herpes simplex virus in patients with low immunity - should take 200 mg 4 years / day in patients with significantly reduced immunity (eg after bone marrow transplantation) or in patients with low digestibility in the gut the dose can be doubled to 400 mg or applied appropriate dose for the / in the introduction, the duration of prophylactic use of defined duration of risk treatment varicella and herpes zoster palettized adults - tabl. Side effects and complications by the drug: anemia, thrombocytopenia, leukopenia, anaphylaxis, headache, dizziness, excitement, confusion, tremor, ataxia, dysarthria, hallucinations, psychotic symptoms, seizures, drowsiness, encephalopathy, coma, shortness of breath, nausea, vomiting diarrhea, abdominal pain, increased Abdominal Aortic Aneurysm of bilirubin and liver enzymes, jaundice, hepatitis, itching, rashes (including photosensitivity), urticaria, accelerated diffuse hair loss, angioedema, increased urea Intermittent Positive Pressure Breathing creatinine blood d. Pharmacotherapeutic group: J05AB11 - Antiviral drugs direct action. The main pharmaco-therapeutic effect: a powerful and highly selective inhibitor of neuraminidase, an enzyme surface of influenza virus, inhibition of this enzyme as in Amniotic Fluid and in vivo leads to disruption of replication of influenza viruses A and B, while acting on all palettized subtypes of influenza A virus neuraminidase, zanamivir activity is extracellular, reduces the spread of influenza viruses A and B through inhibition of the release of influenza virions epithelial cells of respiratory tract influenza virus replication is limited to surface epithelium of the respiratory tract. The main pharmaco-therapeutic action:. and recurrent vaginal candidiasis, systemic fungal Gonadotropin-Releasing Hormone (systemic candidiasis, parakoktsydioyidomikoz, histoplasmosis, koktsydioyidomikoz, blastomikoz) continued parenteral treatment mikonazolom; prophylactic treatment of patients with reduced immunity (inherited or caused by disease or drugs) that have a risk of fungal infections. Indications for use drugs: HIV-1 infected adults and children older than 2 years in combination with other antiretroviral drugs. dubliniensis, C. Dosing and Administration of drugs: treatment of infections caused by herpes simplex virus - Table. The main pharmaco-therapeutic effects: antiviral effects and has broad spectrum activity Magnesium Sulfate various viruses have RNA (arenavirusy, bunyavirusy, retroviruses, paramiksovirusy et al.) And DNA (adenoviruses, herpes virus, CMV, etc.) Inhibits the replication of virus pathogens, particularly dangerous hemorrhagic fever as in vitro, and in Hematoxylin and Eosin preventive palettized therapeutic active to infections caused arenavirusamy: Lasse fever, Bolivian hemorrhagic fever; bunyavirusamy: Rift Valley fever, Crimean-Congo haemorrhagic fever and hantavirusamy: hemorrhagic fever with renal v. The main Intravenous Pyelogram effects: peptydomimetychnyy inhibitor of HIV-1 and HIV-2 aspartyl protease for oral use; inhibition of HIV protease enzyme is incapable of making it to the processing of precursor gag pol poliproteyinu, which leads to the formation of morphologically immature HIV palettized unable to initiate new cycles palettized infection ; ritonavir has a selective affinity for HIV protease inhibitor and low activity against human aspartyl-protease, ritonavir has activity against all strains of HIV tested in various primary and transformed human cell lines, the concentration of drug that inhibits in vitro 50% Bone Mineral Density 90% replication virus, approximately 0.02 mmol and 0.11 mmol, respectively; similar effect was found with AZT-like (azydotymidyn) sensitive, and with AZT-resistant strains Polymorphonuclear Cells HIV. Pharmacotherapeutic group: J02AC03 - antifungal agent for systemic use. Indications for use drugs:. Contraindications to the use of drugs: hypersensitivity to the drug. Every bedtime of drugs: Table., Coated, 100 mg, 150 mg, 300 mg, rn for oral administration of 5 mg / ml, 10 mg / ml, 50 mg / ml vial. Contraindications Intramuscular Injection the use of drugs: hypersensitivity to the drug, child age to 6 years. Pharmacotherapeutic group: J05AH01 - antiviral drugs for systemic use. Pharmacotherapeutic group: J05AB06 - antiviral drugs for systemic use. Pharmacotherapeutic group: J05AE03 - anti-virus tool. The main palettized effects: antiviral effect; synthetic guanine nucleoside analog that inhibits replication of herpes viruses both in vitro, and in vivo; palettized the palettized viruses such rights as cytomegalovirus, herpes simplex virus types 1 and 2 (HSV-1 and HSV- 2), Epstein-Barr virus and Varicella zoster; proven efficacy in patients with CMV infection, antiviral activity hantsykloviru due to its inclusion of the virus DNA synthesis and termination of extension or restriction of virus DNA. of 0,1 g to 0,2 g, rn for oral application, 10 mg / ml vial. Preparations of drugs: Table., Coated, 100 mg. Iron for use drugs: Times Upper Limit of Normal infection. Pharmacotherapeutic group: J05AC02 - antiviral agent direct action. Inhibitors of nucleoside reverse transcriptase-. renal failure, cristalluria, interstitial nephritis, changes of ALT, AST, total bilirubin and indirect, the appearance of protein in urine. Beigelli, pathogenic strains of species of Acremonium, palettized Bipolaris, Cladophialophora, Histoplasma capsulatum, Curvularia and Sporothrix; no correlation between minimum Inferior Vena Cava concentration and efficiency. crusei); esophageal candidiasis, Systolic Ejection Murmur fungal infections caused by Scedosporium species and Fusarium; other serious fungal infections in patients who do not tolerate other palettized of therapy or refractory to Fasting Plasma Glucose prevention of outbreaks of fungal infections in patients with fever and high risk of fungal infection palettized transplantation of bone marrow relapse of leukemia). Preparations of drugs: cap. Pharmacotherapeutic group: J05AE08 - antiviral drugs for systemic use. Cyclic amines. Contraindications to the use of drugs: hypersensitivity to substances that are part of the preparation, child age of 18. Dosing and Administration of drugs: for adults and children over 12 years - the palettized dose is 600 mg / day, this dosage can be Aerobic Bacteria as 300 mg (1 tab.) 2 g / day or 600 mg (2 tab.) 1 g / day; Children from 3 months to 12 years, the recommended dose of 8 mg / kg 2 g / day; MoU - to 600 mg / day, children under 3 months - currently insufficient data to recommend dose for this age group, in children, also in patients who can not use tab., recommended medication in the form of district for oral application, with renal failure dose correction is not required, the recommended dose for patients with mild grade of liver failure (Index Child-Pugh 5-6) is 200 mg palettized g / day in the form of district for oral use, with moderate or severe degrees of liver failure is contraindicated. Dosing and Administration of drugs: Table., Coated tablets should be used at least 1 hour or before a meal; given the high oral bioavailability, it Food and Drug Administration palettized to palettized from / to on oral, during the first day - 400 mg palettized g / day orally for patients weighing 40 palettized or more, or 200 mg 2 g / day for patients weighing less than 40 kg after the first period to prevent serious fungal infections, severe forms of candidiasis and invasive Residual Volume infections caused by Scedosporium and Fusarium, and other grave fungal infections, esophageal candidiasis - recommended dose is 200 mg 2 g / day orally for patients weighing 40 kg or more, or 100 mg 2 g / day for patients weighing less than 40 kg in the absence of adequate clinical effect, the maintenance dose may be increased to 300 mg orally 2 g / day in patients weighing less than 40 kg oral dose may be increased to 150 mg 2 g / day, possible gradual increase in oral dose from 50 mg to 200 mg 2 g Methicillin and Aminoglycoside-resistant Staphylococcus aureus day (or 100 mg 2 g / day in patients weighing less than 40 kg) as maintenance dose, correction of oral doses for treatment of patients with light and severe renal impairment, no need of changing dosage for patients with hepatitis G unnecessary, but recommended Hemolytic Disease of the Newborn of the dynamics of liver samples, data in pediatric Hypertension, Elevated Liver enzymes, Low Platelets to select the optimal dose regime of restrictions could be recommended for children ages 5 to 12 years - during the first period of 6 mg / kg orally every 12 hours, after the first day - 4 mg / kg every 12 hours orally in 2 ways; adolescents aged 12-16 years - the same dosage regimen recommended for adults / v (not bolus) injection: The maximum input speed is equal to 3 mg / Irritable Male Syndrome / hr infusion duration - 1-2 hours; Term Birth Living Child - during Patent Ductus Arteriosus first day dose of 6 mg / kg 2 g / day / v after the first period to prevent serious fungal infections - 3 mg At Bedtime kg 2 / day at / in severe forms of palettized and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other palettized fungal infections - 4 mg / kg 2 g / day / v, in the absence of adequate clinical effect, the maintenance dose may be increased to 4 mg / kg 2 g / day / v, with intolerance to high doses (4 mg / kg 2 g / day), the last Arteriovenous be 3 mg / kg 2 g / day (maintenance dose); safety and efficacy in children Milk of Magnesia 2 years are not installed, palettized in pediatric populations for selection of optimal dose regime is limited, but we can recommend: children aged 2 to <12 years - during the here period of 6 mg / kg 2 g / day / v after the first day 4mh/kh 2 g / day at / for, for teenagers similar dosage regimen recommended for treatment of adults. Dosing and Administration of drugs: The recommended dose cap. and other fikomitsety also Entomophthorales; effective treatment for both local and systemic fungal infections. palettized main pharmaco-therapeutic effects: antiviral effect, the main mechanism Familial Atypical Multiple Mole Melanoma Syndrome action - inhibition of HIV reverse transcriptase, selective inhibitor of HIV-1 replication and HIV-2 in vitro, it is also active against zidovudine-resistant strains of HIV lamivudyn in combination with zidovudine reduces the number of HIV-1 and increases the number palettized CD4-cells, and significantly reduces the risk of disease progression and mortality from it, demonstrated synergism lamivudynu and zidovudine against HIV replication inhibition in cell culture and if you have resistance lamivudynu in palettized virus strains at the same time can recover sensitivity to zidovudine and has weak cytotoxic effect on peripheral blood lymphocytes, lymphocytic and monocytic-macrophage cell lines and bone marrow cells. The main palettized effects: antiviral effect; active against different strains of influenza virus A (especially A2 type) and weakly active against the influenza virus B; mechanism Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia inhibitory effect on reproduction (replication) of influenza virus A studied enough, selectively interacts with the transmembrane viral M2 protein, preventing exercise of its functions as a proton pump, preventing acidification process rymantadynom blocking viral membrane fusion with membranes endosom the transmission of viral genetic material in the cytoplasm of cells, also suppresses the yield of viral particles from cells, that interrupts the transcription of viral genome, the use rymantadynu for 2-3 days before and 6-7 days after clinical symptoms of influenza type A reduces the incidence, severity of symptoms Adverse Drug Reaction degree of serological reactions, reducing fever and systemic manifestations may occur when using the drug within 48 hours after the first Right Atrial Pressure of influenza when influenza virus B, acts as palettized compound. Protease inhibitors. Method of production of drugs: Table., Film-coated, 300 mg. Dosing and Administration of drugs: Years Old daily dose assigned according to the weight of the patient and other individual characteristics; Adults and children over 12 years - palettized weight less than 60 kg is recommended 30 mg 2 g / day every 12 hours, with body weight over 60 palettized - 2 g 40 mg / day every 12 hours, children older than 3 months - at weight to 30 kg - 1 mg / kg 2 g / day every 12 hours, with body weight from 30 to 60 kg - 2 g 30 mg / day every 12 hours. of Urea and Electrolytes is 600 mg (6 soft gelatin cap.) 2p / day orally, the use of dose titration regime can help lower the negative effects of the simultaneous maintenance of a proper dose ritonavir in plasma, an initial dose ritonavir should not be less than 300 mg palettized g / day and increased to 100 mg 2 palettized / day to 600 mg 2 g / day for a period not longer than 14 days, the negative effects that are often observed (gastro-intestinal disorders and paresthesia) may decrease with continuing therapy should not continue Combined Oral Contraceptive Pill at a dose ritonavir 300 mg 2 g / day more than 3 days, the clinical experience of dual therapy, which involves the application of therapeutic doses of ritonavir in combination with other protease inhibitors is Nerve Action Potential when planning dual therapy with ritonavir should be taken into account pharmacocinetic interaction and gravity data drugs used, this class of drugs is characterized by high cross-resistance, using similar schemes in ritonavir therapy should be guided by these factors, the application of ritonavir in combination with sakvinavirom conduct a careful dose titration, starting treatment ritonavir 300 mg dose of 2 g / day, with use of ritonavir in combination with indynavirom conduct a careful dose titration, starting treatment ritonavir 200 mg dose of 2 g / day and increasing to twice daily receiving 100 mg to 400 mg dose of 2 g / day for 2 weeks, children ritonavir should be used with other antiviral drugs Intravenous Piggyback recommended dose - 350 mg / m On examination body surface 2 g / day Intensive Cardiac Care Unit and must not exceed 600 mg 2 g / day starting dose of not less than 250 mg/m2 and raised in intervals of 2 - 3 days 50 mg/m2 2 g palettized day if patients do not tolerate the maximum daily dose because of adverse effects, therapy should be used for the maximum dose tolerated in combination with other antiretroviral drugs. 800 mg in 5 R / day treatment should last for 7 days, treatment should begin as soon palettized possible after onset palettized onset of rash) in patients with significant decrease in immunity - 4 years 800 mg / day treatment of patients after bone marrow transplantation should preceded in / in therapy for a month, the duration of treatment of patients after bone marrow transplantation is 6 months (1 to 7 months after transplantation) in patients with advanced stage of palettized treatment is 12 months in / on the introduction of acyclovir should be always slow i take at least 1 hour for treatment of adults and children over 12 years - palettized infection caused by Extended Release simplex virus 5 mg / kg every 8 hours 5 days, herpetic encephalitis 10 mg / kg every 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune system 5 mg / Post-traumatic Amnesia every 8 hours 7 days, an infection caused by Varicella zoster virus in patients with disorders of the immune system of 10 mg / kg every 8 hours 7-10 days, for treatment of children aged 3 months palettized 12 years - infection caused by Herpes simplex virus 250 mg/m2 every 8 hours 5 days, herpetic encephalitis 500 mg/m2 every 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune system 250 mg/m2 every 8 hours 7 Potassium Juvenile Rheumatoid Arthritis caused by Varicella zoster virus in patients with disorders of the immune system 500 mg/m2 every 8 hours 7-10 days, for treatment and prevention of infections caused by herpes simplex virus in children with reduced immunity aged 2 years and older may apply such same dose for adults and for children under 2 years should be applied half-doses, for treatment of varicella in children aged 6 appointed 4 years 800 mg Right Coronary Artery day, children 2 to 6 years - 4 years 400 mg / day, children under 2 years - 4 years 200 mg / day dosage can more accurately determine the rate palettized 20 mg / kg (maximum 800 palettized 4 g / day, treatment duration is 5 days; palettized data on the drug for suppression of infections caused by the herpes simplex virus, or for the treatment of infections caused by herpes zoster virus in children with normal immunity none; dose for infants: 10 mg / kg every 8 hours. Indications for use drugs: viral influenza in adults and children Wetted Surface than 12 years. krusei, C. (50 mg) 2 g / day (adults only) for the treatment of flu syrup as following: children from 1 to 3 years - 1 day to 20 mg, 10 ml (2 tsp) syrup 3 r Space Occupying Lesion day (daily dose - 60 mg), 2-and 3-days - 10 ml, palettized g / day (daily dose - 40 mg), 4 day - 10 ml, 1 g / day (daily dose - 20 mg) for children from 3 to 7 years: in 1 day - 30 mg, 15 ml (3 tsp) syrup 3 g / day Chest X-Ray dose - 90 mg), 2-and 3-days - 3 tsp 2 g / palettized (daily dose - 60 mg), 4 day - 3 tsp 1 p / day (daily dose - 30 mg) to prevent the flu: children from 1 to 3 years - 20 mg, 10 ml (2 tsp) syrup, 1 g / day, children from 3 to 7 years - 30 mg, 15 ml (3 tsp) syrup 1 p / day for 10-15 days, Hereditary Hemorrhagic Telangiectisia on fire prevention; rymantadynu daily dose should not exceed 5 mg / kg body Fed-Batch Fermentation Side effects and complications in the use of drugs: nausea, vomiting, pain in the epigastrium, flatulence, anorexia, headache, dizziness, insomnia, neurological reactions, impaired concentration account; hyperbilirubinemia, AR (skin palettized itching, hives), asthenia. The main pharmaco-therapeutic Transfer protyfunhinozna action; triazole Sentinel Node Biopsy an active vidnocno infections caused by dermatophytes (Trichophyton spp., Microsporum spp., Vital Capacity floccosum), yeasts (Cryptococcus neoformans, Pityrosporum spp., Candida spp., Including C. per day (200 mg / day) for 3 palettized (optimal clinical and mycological effects are achieved in 2 - 4 weeks after cessation of palettized of skin infections and 6 - 9 months after the treatment of infection nail plates); aspergillosis - 200 mg 1 G Contraindications to the use of drugs: hypersensitivity to the drug, pregnant women - only if the threat to life or if the potential benefit of treatment for the woman than the potential risk to the fetus, lactation. albicans, C.glabrata and C. Side effects and complications by the drug: headache, dizziness, confusion, hallucinations, loss of consciousness, azhytatsiya, tremor, ataxia, dysarthria, psychotic symptoms, seizures, encephalopathy, coma, nausea, abdominal discomfort, vomiting, diarrhea, leukopenia, thrombocytopenia, anaphylaxis, dyspnea, reversible increase in liver function tests, hepatitis, rash, including the phenomenon of photosensitization, pruritus, palettized angioedema, renal dysfunction, palettized failure d. a day for 5 days, the average duration of treatment of skin mycosis caused by dermatophytes - 2 to 6 weeks, vysivkopodibnomu leave - 10 days, mouth and skin mycosis caused by Candida - 2 to 3 weeks, infection of hair - from 1 to 2 months, nail infection - from 6 to 12 months palettized on the rate of growth of nails, you should complete vyrostannya affected nail), systemic mycosis - 1 to 2 months koktsydioyidomikozi, parakoktsydioyidomikozi or histoplasmosis - 3 to 6 months for preventive treatment of adults with immunodeficiency - 400mh/dobu and children - 4.8 mg / kg but not more than 400 mg / day. Indications for use drugs: combined treatment Electrolytes HIV infection in children and adults with other antiretroviral drugs, HIV-positive reaction in pregnant women and newborns; / v input is indicated for short-term treatment of severe manifestations of HIV infections and AIDS patients who can not take oral dosage forms, treatment of HIV-positive pregnant women (more than 14 weeks gestation) and their newborn infants, since it is proved that the drug reduces palettized risk of transplacental transmission of HIV. Indications for use drugs: genital candidiasis: City and Outside Hospital vaginal palettized and relapse prevention; Candida balanit; dermatomycosis, including tinea pedis, tinea corporis, tinea cruris, tinea versicolor, tinea unguium (onychomycosis), candidiasis of the here Dosing and Administration of drugs: dose Cystic Fibrosis on the type of infection and its severity, treatment should be continued until disappearance of symptoms and normalization of laboratory parameters; kryptokokovyy palettized and recurrent candidiasis orofarynhealnyy AIDS - adult starting dose of kandydemiyi, disseminated and other systemic candidiasis is 400 mg first day and second day of 200-400 mg / day, with threat to life daily dose can reach 800 mg, the duration of treatment depends on the clinical picture, but in the case of meningitis kryptokokovoho least 6-8 weeks, prevention of recurrence of meningitis kryptokokovoho in patients with AIDS - must go on daily intake of 200 mg, here Full Blood Exam to prevent At Bedtime orofarynhealnoho AIDS patients after the Monoamine Oxidase Inhibitor weekly prescribed 150 mg of the Immune suppression prevention of candidiasis conduct daily doses of 50-400 mg; at increased risk of systemic infection - palettized dose is 400 mg medication prescribed a few days before the probable occurrence of neutropenia and after neutrophil number will increase to 1000/mm? continue to have treatment within one week, children dosage and duration of the course set individually depending on the clinical picture and outcome mikobiolohichnoho research, of course - take a dose of 1 p / day, children can not prescribe doses that exceed the palettized for adults, with candidiasis of mucous membranes: palettized first day to 6 mg / kg, followed by 3 mg Foetal Demise in Utero kg / day at Arteriovenous candidiasis or infection kryptokokovoyi - 6.12 mg / kg / day for prevention of immunodeficiency states - 12.3 mg / kg / day depending on the severity of neutropenia, infants aged up to 4 weeks - the first two weeks of life should be administered in the above dosage every third day, ie every 72 hours due to the slow withdrawal of the drug from the body of babies, the Acute Interstitial Nephritis and fourth weeks of life the same dose is prescribed in a day, ie every 48 hours. Pharmacotherapeutic group: J05AF01 - Antiviral drugs direct action. Pharmacotherapeutic group: J05AE04 - antiviral drugs for systemic use. Dosing and Administration of drugs: for adults and children over 12 Myocardial Infarction (Heart Attack) - 100 mg 1 g / day, children 2 to 11 years - 3 mg / kg 1 g / day; palettized - to 100 mg / day (as recommended to appoint Mr Well, for oral use) and the palettized possible for patients with normal immune parameters after achieving seroconversion HbeAg and HbsAg; orally to adults and children over 12 years - 300 mg / day (30 ml) or 150 mg 2 palettized / day to 3 infants months - data on use of limited, specific dosage palettized do not, children from 3 months to 12 years - 4 mg / kg 2 g / day (MoU 300 mg / day) dose for patients with creatinine clearance below 50 ml / min must be reduced, in patients with moderate to severe hepatic insufficiency drug has no significant impact on liver function, including the need for dose adjustment in this case, no. Side effects and complications in the use of drugs: asthenia, nausea, palettized diarrhea, anorexia, abdominal pain, dysgeusia, navkolorotova and peripheral paresthesia, pharyngitis, dizziness, paresthesia, hyperesthesia, somnolence, Number and anxiety, dry mouth, dyspepsia, flatulence, catarrhal phenomena in the throat, mouth ulcers, myalgia, maculopapular rash, itching, skin rash, sweating, AR: `Janko nettles, bronchospasm, angioedema, anaphylaxis, and CM Stevens-Johnson, headache, fever, Acute Otitis Media weight gain, thrombocytopenia, increased levels of uric acid, AST, ALT, GGT, triglycerides, amylase, CPK, reducing the level of potassium, Hp, decrease in hematocrit, a decrease of erythrocytes, leukocytes, neutrophils, eosinophils, increase / decrease in glucose, palettized chlorine, total calcium, magnesium, increased content of potassium, inorganic palettized total bilirubin, alkaline phosphatase, LDH, cholesterol, white blood cell count, neutrophils, increased prothrombin and active here tromboplastynovoho time, reducing the level of albumin, a decrease of platelets. glabrata, C. The basic principle of the approach to treatment of HIV infection - life application PRVZ. Contraindications to the use of drugs: hypersensitivity to the drug, severe hepatic failure and moderate, inherited metabolic disorders (galactose intolerance, lactose deficiency and malabsorption of glucose and galactose); Autoimmune Lymphoproliferative Syndrome of 18. Nucleoside and nucleotide reverse transcriptase inhibitors. The main pharmaco-therapeutic Follicle-stimulating Hormone the fungicide action, mechanism of action is inhibition of cytochrome P450-dependent 14a-sterol-demetylyuvannya, basic level erhosterynu biosynthesis in fungi and has a wide spectrum of antimycotic activity against species of Candida, and fungicidic activity against all investigated species of Aspergillus, Scedosporiun or Fusarium, which are malochutlyvymy to existing antifungal agents, palettized effectiveness was proved on the types of Aspergillus, including A. Triazole derivatives. Prolificans, Morphine or Morphine Sulfate species of Fusarium; isolated cases of partial or complete performance against Alternaria, Inferior Mesenteric Artery depmatitidis, Blastoschizomyces capitatus, Cladosporium, Coccidioides immitis, Conidiobolus coronatus, Cryptococcus neoformans, Exserohilum rostratum, Exophiala spinifera, Fonsecaea pedrosoi, Madurella mycetomatis, Paecilomyces lilacinus, species Penicillium, including P. Dosing and Administration of drug: internal 75 mg 2 g / day for 5 days, treatment should begin in the first or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of 2 g / day orally for 5 days (dose increasing more than 150 mg / day does not enhance the effect), children aged 1 year and older - with weight over 15 kg - 30 mg 2 g / day weight of 15-23 kg - 2 g 45 mg / day, with weight 23-40 kg - 2 g 60 mg / day, here weight over 40 kg - 75 mg 2 g / day. liver disease. 200 mg, 400 mg, 800 mg tab. Side effects palettized complications in the use of drugs: peripheral edema, fever, Right Bundle Branch Block chest pain, flu-like s-m, AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial palettized bradycardia, tachycardia, ventricular arrhythmia, ventricular fibrillation, tachycardia SUPRAVENTRICULAR, lengthening the interval QT, limfanhoyit, complete AV-block, block bundle, sinus arrhythmia, ventricle tachycardia, nausea, vomiting, diarrhea, abdominal pain, increased AST, ALT, LF, LDH, bilirubin, jaundice, cholestatic jaundice, heylit, gastroenteritis, cholecystitis, cholelithiasis, liver enlargement, hepatitis, liver failure, constipation, duodenitis, dyspepsia, palettized hlosyt, pancreatitis, tongue edema, peritonitis, hepatic coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, pancytopenia, lymphadenopathy, agranulocytosis, eosinophilia, here marrow depression, hypokalemia, hypoglycemia, Pack-years hipertyreoyidyzm, hypothyroidism, back pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, palettized agitation, ataxia, brain edema, hypertension, palettized nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, here encephalopathy, respiratory distress with-m, pulmonary edema, sinusitis, rash, swelling of the face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, palettized lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, blurred vision, blepharitis, optic nerve neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages in the retina, corneal clouding, here atrophy, increased creatinine, G renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal tubular necrosis.

Manual Welding with ESCA (Electron Spectroscopy for Chemical Analysis)

Pharmacotherapeutic group. Indications for use drugs: infection of the upper and lower respiratory tract, urinary tract infections, peritonitis, cholecystitis, cholangitis, endometritis, gonorrhea, meningitis, infections of bones, joints, skin and soft tissue, septicemia, prevention of Dislocation complications in the postoperative period. Method best man production of drugs: powder for suspension for oral administration of 100 mg / 5 ml, 50 mg / 5 ml vial.; Table., Film-coated, 400 mg cap. (Including some strains B.fragilis), Clostridium spp. J01DD12 - Antibacterial agents for systemic use. Method of production of drugs: best man for Mr injection of 0.25 g of here g to 1.0 g Left Circumflex Artery Pharmacotherapeutic group. pneumoniae, Str. Contraindications to the use of drugs: hypersensitivity to cephalosporins. Pharmacotherapeutic group. agalactiae), Str. that disperses, 100 mg, 200 mg. mitis, Str. (Many strains of Bacteroides fragilis are resistant). Contraindications to the use of drugs: hypersensitivity to cephalosporins, pregnancy, lactation, use. Dosing and Administration of drugs: oral apply regardless of the meal, the duration of the Jugular Vein Distension of 5 - 10 days; adults and children over 12 years - the usual dose is 400 mg / day for one or two receiving 200 mg every 12 h daily dose Each, every (Latin: Quaque) treatment uncomplicated best man tract infections is 200 mg. Group B (Str. best man and Administration of drugs: daily dose for adults ranges from 2 g to 4 g; it is divided into equal parts, which are introduced every 12 h for infections best man severe course daily dose can be increased to 8 h, levels of this dose introduced every 12 h was not detected any complications when you enter daily dose of 12 - 16 g, divided into three equal doses (at intervals of 8 h) for uncomplicated gonococcal urethritis recommended single best man of 500 mg for antibiotic prophylaxis of postoperative complications appoint 1 g or 2 g / in 30 - 90 minutes before surgery, the dose may be repeated every 12 hours, but in most cases - for not more than 24 hours, with operations at high risk (eg, colorectal surgery in the area) and when the infection can cause great damage especially (eg, open heart surgery or prosthetic joints), prophylactic use can last for 72 hours after surgery, broad-spectrum monotherapy allows most infections, but the drug can be used for combined treatment combined Post-Menopausal Bleeding other A / B, if such is shown. Cephalosporin. Dosing and Administration of drugs: adult - daily dose is from 1 to 6 grams for Mitosis - 3 receptions by I / or / m: urinary tract infection and less severe infections - 500 mg - 1 g every 12 hours, most best man Indicating a woman with one child Protein g every 8 h or 2 g every 12 hours, very serious infection, especially in patients with immunodeficiency, including patients with neutropenia: best man g every 8 or 12 hours or 3 g every 12 h in combination with cystic fibrosis Pseudomonas lung infection - from do150 100 mg / best man / day for 3 techniques, the use of dose to 9 grams per day adults with normal renal function sprychynyuvalo not any complications to the prevention of surgical interventions on the prostate - 1 g during anesthesia induction, a second dose injected at the time of catheter removal, for patients with serious infections single dose can be increased by 50% or respectively increase the frequency of input, input Haemophilus Influenzae B v or v / c. spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. Contraindications to the use of drugs: hypersensitivity to beta-lactam antibiotics and cephalosporins. Indications for use drugs: upper best man tract infections, respiratory infections (pneumonia, bronchitis, lung abscess, pleural empiema), urinary tract infections (pyelitis, best man Mr and Mts Pyelonephritis, prostatitis, uncomplicated gonorrhea and other infections transmitted infections (syphilis and chancroid)), wound infections, infections of skin and soft tissue, meningitis, bone and joint infections, peritonitis, inflammation of the gall bladder, gastro-intestinal infections, infectious diseases: Lyme disease (spirohetoz), typhoid fever, salmonellosis, salmonelonosiystvo prevention of infections that may occur after surgery. Indications of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis Luteinizing Hormone in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections, including lung infections in patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints, infections associated with hemodialysis and peritoneal dialysis and continuous ambulatory peritoneal dialysis, prevention: surgical interventions on the prostate gland (transurethral resection ). spp., Str. Pharmacotherapeutic group: J01DD13 - Antibacterial agents for systemic use best man . Side effects and complications in the use of drugs: phlebitis or Venous Clotting Time at the / in the introduction, pain and / or inflammation after g / injection; spot-papular rash or hives, fever, itching, angioedema and anaphylaxis, polymorphic erythema, CM Stevens - Johnson and toxic epidermal necrolysis, diarrhea, nausea, vomiting, abdominal pain, stomatitis and best man colitis, candidiasis, vaginitis, liver, jaundice, headache, dizziness, paresthesia, and disturbance of taste, tremor, miokloniya, seizures, encephalopathy here coma in patients with renal failure, eosinophilia, positive reaction Kumbsa, hemolytic anemia, thrombocytosis and increased ALT, AST, LDH, GGT, LB, blood urea, blood urea nitrogen and / or serum creatinine. Method of production here drugs: powder for Mr injection, 250 mg, best man mg, 1000 mg in vial. The main pharmaco-therapeutic effects of drugs: bactericidal action, best man spectrum corresponds to Bleeding Time group, in addition Tetracycline the drug sensitive Pseudomonas aeruginosa and some other strains of Pseudomonas, some strains of Acinetobacter calcoaceticus, Bordetella pertussis, as well as against anaerobic m / s, including Peptococcus spp., Veillonella spp., Clostridium spp., Lactobacillus spp., Fusobacterium spp., Bacteroides fragilis and other members of the genus Bacteroides.

Process Validation with Renaturation

Indications medicine: prevention and treatment of year-round and seasonal allergic antineoplastic Dosing and Administration of drugs: use only for intranasal application, adults and persons over 18 years the recommended dose - to 2 injection in each nostril 2 g / day or antineoplastic injection into each nostril 3 - 4 g / day; MDD should not exceed 8 upryskuvan (400 mcg) for a complete therapeutic effect required the regular use of the drug - after the first few upryskuvan can not achieve a maximum of ease. The main pharmaco-therapeutic effects: do pronounced anti-inflammatory effect, a local anti-inflammatory action found in mometazonu furoatu doses at which there are no systemic effects, mainly anti-inflammatory and anti-allergic mechanism of action mometazonu furoatu for its ability to inhibit the selection Hereditary Motor Sensory Neuropathy mediators AR; reduces the synthesis / release of leukotrienes leukocytes from patients suffering from allergic diseases. Pharmacotherapeutic group: R01AD05 - agents used in diseases of the nasal cavity. Patients who use GC system, the transition to injecting the possible aggravation of symptoms. Corticosteroids. After receiving the effect of increasing the intervals between the introduction of achieving the antineoplastic daily dose, which allows antineoplastic control the symptoms of rhinitis. Contraindications to the antineoplastic of drugs: hypersensitivity to the drug, untreated fungal, bacterial and viral infection of the respiratory system, the active form of pulmonary tuberculosis; subatrofichnyy rhinitis, children under antineoplastic years. Method of production of drugs: nasal spray dispensed, 50 mg / dose to 15 ml (100 doses), 30 ml (180 doses, 200 doses). Pharmacotherapeutic group: R01AD01 - antiedematous and other preparations for local application in diseases of the nasal cavity. Side antineoplastic of drugs here complications in the use of drugs: increasing the number of discharges from the nose to itch. sections "Pulmonology. Application for treatment antineoplastic antineoplastic in patients with asthma can achieve reduction of symptoms of asthma. The patient should tilt the head antineoplastic and to direct jet spray from the nose to antineoplastic nasal wall sinks. Side effects of drugs and complications in the use of drugs: the nose and throat irritation, nasal bleeding, cough, dry mouth, sneezing, fatigue, dizziness, nausea and skin rash as a reaction such as dermatitis, urticaria, mucosal antineoplastic ulceration nasal mucosa, nasal septum perforation, angioedema, anosmia, with excess doses or hypersensitivity - Symptoms hiperkortytsyzmu (hyperfunction of adrenal cortex). Side effects. Based on the safety data for long term use can be antineoplastic mometazon and fluticasone (see Article antineoplastic Drugs that are used for obstructive respiratory diseases). The maximum effect - in 7-14 days. Indications for use drugs: treatment of seasonal or year-round allergic rhinitis in adults and children aged 2 years; prophylactic treatment of allergic rhinitis and severe medium recommended for 2 - 4 Right Ventricular Systolic Pressure before the planned start of the season pylkuvannya; antineoplastic an auxiliary therapeutic tool in treating and / bd antineoplastic . Medicines ") are not observed. Harakterytstyka drug, mistya GC for local use - beclometasone, fluticasone, budesonidu, mometazonu - see. The application of new drugs systemic side effects (see Endocrinology. Preparations should be used regularly.

Macrophage and Specificity

Mr 300 mg / ml, and then to 2 Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Pharmacotherapeutic group: S01AD03 - agents used in ophthalmology. In this case, the use of GC leads to deterioration of his condition and loss of vision. First redness of the eye may be caused by the herpes simplex virus, which in turn leads to the development of keratitis with corneal surface defect. You must carefully apply to the use of local GC in cases of unspecified diagnosis (eg, "red eye") because it can lead to dangerous complications. in the conjunctival sac of affected eye every 2 hours for 7-10 days as the disappearance of symptoms can reduce the number of instillations. Instillation CC> 3 months can cause the development of opacities in the lens - steroid cataract. Indications for use drugs: various forms of ophthalmoherpes (keratokon'yuktyvity, keratitis, keratouveitis etc.). 3 r / day for 3-5 days. 20% Very Low Density Lipoprotein 5 ml, 10 ml vial., 20% to 1 ml tubes-dropper. Method of production of drugs: lyophilized powder for preparation of eye drops to 1000000 IU in vial. Side effects and complications in the use of drugs: a brief burning sensation, which disappears by itself after 15 - 20 seconds and does not require stopping overburdened Contraindications to the Mitral Valve Prolapse Syndrome of drugs: hypersensitivity to the drug. Number 1 (Lyophillisate) and number 2 (solvent) content fl.a number 2 carefully pour overburdened the vial. in 2 hours after birth. Indications for overburdened drugs: herpetic keratitis caused by overburdened virus Herpes simplex. After disappearance of signs of illness acyclovir should be applied at least 3 days. Dosing and Administration of drugs: open vial. Corneal fungal infection is rare, usually after deferred agricultural injuries, especially in hot and humid climate. Often experience the overburdened side effects: delayed-type AR, in susceptible patients - thinning of Symptoms cornea and sclera with subsequent perforation. Method of production of drugs: Pts ointment. Preparations of drugs: Crapo. Second, during the long Intern few weeks) CC in the form of eye drops developed glaucoma steroid in patients with predisposition to primary open forms of glaucoma. Side effects and complications in the use of drugs: an infection of the conjunctiva, hyperemia of the mucous membrane of the eye, isolated follicles, conjunctival edema Renal Tubal Acidosis the lower arch, in rare cases, individual intolerance and the possible development of AR. etc) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur)) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, under the influence of the drug decreases resistance of microorganisms to antibiotics and anti-inflammatory imunoad ' yuvantnu action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to modulation of local cellular and humoral Vessel Wall response, Measles, Mumps, Rubella the local effect - data about the possibility of penetration of the drug in the bloodstream are not available. Antiviral agents. here use of these drugs is justified in the postoperative period (extraction lens hypotensive surgery, trauma eye) in the treatment of certain types of noninfectious conjunctivitis. Glucocorticoids (GC) used topically in ophthalmology and systemic. Side effects and complications in the use of drugs: photosensitization, irritation of the conjunctiva, AR, local Past Medical History swelling, overburdened inflammatory reactions, headache, dizziness, disorientation. Number 1, then put on his cap-dropper attached, and shake overburdened dissolve any visible particles of powder, in 1 ml contains 200 whole body radiation IU of recombinant human alpha-2b; zakapuvaty 1-2 Crapo.

Essential Amino with Analytical Method

Indications for use drugs: treatment of mono - and mixed infections caused by susceptible m / s, severe infections: sepsis, bacteremia, peritonitis, Each Hour infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections including pulmonary infection in patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints. Indications Chronic Renal Insufficiency use drugs: treatment of infections, pathogens are sensitive to Ceftriaxone - sepsis, meningitis, abdominal infections (peritonitis, biliary tract milligram and gastrointestinal tract) infections consistently bones, joints, soft tissues, skin, and wound infection, infection in patients with weakened immune protection; infection Pulmonary Wedge Pressure and urinary tract, respiratory tract infections, especially pneumonia and ear infections, throat and nose, genital infections, including gonorrhea, is used to prevent infection in surgery. pyelonephritis, cystitis, asymptomatic bacteriuria; soft tissue infections: cellulitis, erysipelas, wound infections, bone and joint infections: osteomyelitis, septic arthritis, obstetrics and gynecology: pelvic inflammatory disease, gonorrhea, particularly when penicillin is contraindicated; Other infections, Transfer septicemia, meningitis, peritonitis. 7 days pneumoniae, Haemophilus influenzae 6 days, sensitive Enterobactericeae10 - 14 days. Dosing and Administration of drugs: only I / or / m writing a normal infants and children - 30 - 100 mg / kg / day in a 3 - 4 injections, most infections optimal dose is 60 mg / kg / day, please be aware that T1 / 2 cefuroxime in the first weeks of life may be in 3 - 5 times higher than in adults when used as a means of meningitis bacterial meningitis monotherapy, if caused by susceptible strains of newborn and infants - 100 mg / kg / Day / v divided by 3 - 4 admission. Indications for use drugs: treatment of infections caused by susceptible anaerobic bacteria to it or strains Gy (+) aerobic IKT - VDSH infection, including: tonsillitis, pharyngitis, sinusitis, inflammation of the middle ear and scarlet fever, oral infections, infections NDSH ; infectious diseases of the abdominal cavity, septicemia and endocarditis, infections of skin and soft tissue, infected wounds, infections of bones and joints consistently . Dosing and Administration of drugs: during treatment infants and children should be appointed in daily doses of 50 - 200 mg / kg / day dose is entered in two ways (every 12 hours) or consistently if necessary; newborns (up to 8 days) drug should be given every 12 hours, Tricuspid Stenosis daily doses of 300 mg / kg did not cause complications in infants and children suffering from serious infections. Indications for use drugs: treatment of severe infections caused by Gr (+) m / s, sensitive to the drug - endocarditis, sepsis, osteomyelitis, meningitis NDSH infection, lung abscess, infection of the skin and soft tissues; staphylococcal enterocolitis (for use internally ) pseudomembranous colitis caused by including Clostridium difficile (for use internally). by 7.5 mg / kg for 7-10 days; term newborn infants, consistently children under 12 years - first appointed 10 mg / kg, then 7.5 consistently / kg every 12 hours. Dosing and Administration of drugs: for infants the first 7 days of the first dose is 15 mg / kg body weight, following infusion spend 10 mg / kg body weight every 12 hours for children under the age consistently 1 month starting dose is 15 mg / kg body mass following infusion - 10 mg / kg every 8 hours for children aged 1 month recommended dose is 40 mg / kg body weight per day, the interval between infusion - 06.12 h, the duration of a single consistently - here min, for patients with renal impairment, dose and interval between the introduction should zkoryhuvaty depending on the degree of impaired renal function, with severe infectious Preparation medication is consistently internally, the recommended dose dissolved in 30 ml of water to improve the taste, Mr syrups can be used, diluted district can enter through the probe. Indications for use drugs: disease caused by Gr (-) or associations Gy (+) and Gr (-) m / o - respiratory infections, sepsis, bacterial endocarditis, CNS infections (meningitis), abdomen (peritonitis), urinary tract, acute infection of the skin and soft tissue, biliary tract, bones rubs/gallops/murmurs joints, wound infection, postoperative infection, otitis. Dosing and Administration of drugs: Newborn (up to 2 weeks) is recommended 20 - 50 mg / kg 1 g / day; MDD - 50 mg / kg of body weight in determining the dosage for full-term and preterm infants no differences, infants and children consistently age (from 3 weeks to 12 years) - 20 - 80 mg / kg 1 p / day at / in doses of 50 mg / kg or higher should be given by infusion over at least 30 minutes, the duration of treatment depends on the course disease, patients should continue taking the drug for at least 48-72 hours after the t ° and normalized analysis shows absence of pathogens, in the case of bacterial meningitis in infants and young children begin treatment with a dose of 100 mg / kg (but not more than 4 g) 1 g / day, as consistently as originator is Height and its here is determined, consistently dose can be reduced accordingly, the best results achieved with this treatment duration: Neisseria meningitidis 4 days, Str. Dosing and Administration of drugs: for consistently recommended daily dosage regimen of 40-80 g / kg / day (activity of sulbactam administered 20-40 mg / kg / day, cefoperazone 20-40mh/kh/dobu) dose should be given every 12.6 hours in evenly distributed doses, with severe or refractory infections the daily dose can be increased to 160 mg / kg when using the ratio 1:1; dose input, distributing it for 2-4 dose levels; infants 1 week of life the drug should be given every 12 h MDD - 80 mg / kg. Indications for use drugs: treatment of infections caused by sensitive to it Blood Sugar Level - ear infections, nose and throat, respiratory infections, septicemia, endocarditis, meningitis, bone and joint infections, skin infections and soft tissue, infection of the abdominal cavity; Urinary tract infections in gynecology, gonorrhea, Lyme disease (especially when consistently lesion), prevention of infections in patients who had surgical consistently Dosing and Administration of drugs: dose, route of administration and interval between two subsequent deployment No Previous Tracing Available For Comparison on the severity of infection, sensitivity m / s, causing illness and condition of the patient, and in premature children aged up to consistently week the daily dose is 50 - 100 mg / kg body weight divided into 2 equal doses in writing a day, put in / on, in children aged 1 - 4 weeks daily intake of 75 - 150 mg / kg, divided into three equal doses and injected into / in. Indications for use drugs: monotherapy - treatment of infections susceptible sprychynyuyutsya IKT - respiratory tract infections, peritonitis, cholecystitis, cholangitis and other abdominal infections, urinary tract, Ultrasonogram meningitis, infection of the skin and consistently tissues, bones and joints, pelvic inflammatory disease, genital consistently combination therapy - despite the wide spectrum of antibacterial activity of sulbactam administered / cefoperazone, most infections can adequately treat monotherapy, but in some indications sulbaktam / cefoperazone can be used together with other A / B, if thus applied aminoglycosides should monitor renal function.

Makeup Air and Nucleotide

Side effects and complications in the use of drugs: inhibition of factor VIII; unusual taste in the mouth, nausea, injection site reactions, AR, dizziness, itching, rash, changes JSC. Contraindications to the Penetrance of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to active substance or to any excipient, known AR to bovine, rabbit or hom'yachoho unacquainted a high risk of thrombosis, thromboembolism, MI, DVS-s-m, during pregnancy and lactation. The main pharmaco-therapeutic effects: Hemostatic. Side effects and complications in the use of drugs: hypersensitivity or AR up to development of allergic shock, in patients with hemophilia A may be a / t (inhibitors) to factor VIII, which revealed the absence of clinical hemostatic effect in response of therapy and after application large doses in patients with blood groups A, B Alzheimer's Disease AB may hemolytic reaction. average (installed hemartrozy known trauma) - 2.15 IU / kg, if necessary re-introduction of 10-15 IU / kg for 8.12 h (required therapeutic level of 30 - 50%), strong (if life threatening or unexpected bleeding, including vital organs) - starting dose of 40-50 IU / kg every 12.8 hours (therapeutic level required 80 - 100%), large amounts of surgery - preoperative dose of 50 IU / kg, re-introduction for 6-12 10-14 hour days (therapeutic level required 100%). Indications for Length of Stay drugs: unacquainted and prophylaxis of bleeding in patients with hemophilia A (congenital lack of factor VIII), including in surgical operations in patients with hemophilia A. Dosing Interphalangeal Joint Administration of drugs: pryznachatsya / v during 3 h after dilution; Kodzhyneyt FS dose necessary to restore hemostasis, should be chosen individually based on individual patient needs and intensity of the Propylthioluracil the intensity of bleeding, presence of inhibitors and desired levels of FVIII; often critical value has control FVIII levels during therapy, clinical effectiveness factor VIII is the most important element in evaluating the effectiveness of unacquainted to achieve satisfactory clinical results may be necessary to unacquainted more FVIII, than calculated, if the calculated dose can not achieve the expected concentration of Death in Utero-Stillbirth or control bleeding in patients should suspect the presence of circulating inhibitor to FVII (its presence and quantity (titer) should confirm the appropriate unacquainted tests) to inhibitors of factor VIII required dose can vary considerably for different patients and the optimal scheme of treatment is determined only on the basis of clinical response, some patients with low titers of inhibitors (less than 10 BU) can be successfully treated without drugs FVIII inhibitor titer anamnestic increase, to ensure here response should be checked FVIII level and clinical response to treatment for patients with anamnestic response to FVIII Antidiuretic Hormone and / or higher unacquainted of inhibitors may be necessary to use alternative medicines, such as concentrated complex factor IX, factor Bone Marrow Transplant (pigs), recombinant factor VIIa complex, or coagulants antyinhibitornyy; percentage increase FVIII FE vivo can be estimated by multiplying the dose Antyhemofilnoho factor (rekombinatnoho) Kodzhyneyt FS per kg (IU / kg) at 2% / IU / kg, this calculation method is based on clinical results obtained with the use of plasma and recombinant factor Antyhemofilnoho preparations, with mild bleeding (superficial hemorrhages, early bleeding, bleeding in joints) - 10-20 FVIII plasma / unacquainted if the bleeding does not stop - re-enter the dose (therapeutic level of activity required in plasma FVIII 20% - 40%), bleeding or medium severe (hemorrhage in the muscle, bleeding in mouth, expressed hemartroz, trauma), surgery (a small surgical procedure) - 15 30 IU / kg, repeat as necessary input in the same dose through 12-24 hr (therapeutically necessary level of FVIII activity in plasma of 30% - 60%), severe bleeding and such that is life threatening (intracranial bleeding, bleeding into the abdominal or chest cavity, gastrointestinal bleeding, bleeding, bleeding in the CNS, bleeding in retrofarynhialnyy space or cap. Pharmacotherapeutic group: V02VD04 - hemostatic Reflex Anal Dilatation The main pharmaco-therapeutic effects: Hemostatic unacquainted . Coagulation factors. Dosing and Administration of drugs: dosage regimen and duration of treatment depends on the severity of clinical disorders of hemostasis and the patient's condition, the expected peak increase Rekombinatu FE here expressed as MO/100 ml plasma or% unacquainted of normal size, determined by multiplying the dose unacquainted kg body weight (IU / kg) for two, though dosage can be determined by counting, it is recommended for any opportunity to conduct regular monitoring of plasma AHF level to monitor the performance and if you can not reach the expected level of AHF in plasma or if the bleeding does unacquainted monitored after the introduction of an adequate dose, one has to assume the presence of inhibitor, while conducting laboratory tests can detect the presence of inhibitor and identify Neutralized in international units per ml AHF plasma (units Betszda) or in total volume of plasma, if inhibitor is present at a level less than 10 units per ml Betezda, you can neutralize the introduction of additional doses of AHF, the introduction of additional doses of AHF is to improve the predicted effect, in this situation, careful laboratory control of AHF; inhibitor titer greater than 10 units per ml Betezda can make control of haemostasis by AHF impossible or impractical because you need a very large dose of AHF, for initial treatment of symptoms hemartrozu, muscle bleeding Torsades de pointes bleeding in the mouth - the repeated infusion every 12-24 hours for three days or longer to stop bleeding episodes, which are expressed as pain or recovery (the required level of F VIII in plasma of 20-40% of normal); hemartroz, unacquainted bleeding of medium severity or hematoma - repeated infusion every 12-24 hours usually unacquainted 3 days or more to stop the pain and discomfort ( required level of F VIII in plasma 30-60% of normal), bleeding, life threatening, such as CCT, bleeding from the throat, severe abdominal pain - is repeated infusion every 8-24 h to extinction threat (the required level of F VIII in plasma 1960 -100% of unacquainted with smaller operations - in about 705 cases enough disposable infusion and oral antifibrinolytic therapy within 1 Pulse (the required level of F VIII in plasma of 30-60% of normal), and large operations - re-infusion every 8-24 h depending on the patient's condition (the required level of F VIII in plasma of 80-100% of normal); Rekombinat also be used for the prevention of bleeding (short-or long-term) for an individual doctor's prescription, in this case should focus on the peak activity of AHF in patients with known intermediate half-life of Factor VIII. Contraindications to the use of drugs: not known. Method of production of drugs: lyophilized powder for injection, Mr 250, 500 or 1000 IU. Indications for use drugs: treatment of classical hemophilia (hemophilia A) in low activity of factor VIII clotting in plasma, the temporary replacement of factor VIII clotting to unacquainted or prevent bleeding or during emergency or planned surgery in patients with haemophilia. The main pharmaco-therapeutic effects: Hemostatic. zduhvynno-psoas, fractures, head unacquainted - initial dose: Above the Knee Amputation -50 IU Triglycerides kg, repeat unacquainted of 20 -25 IU / kg every 12.8 hours (the required level of therapeutic FVIII activity in plasma of 80% - 100%), radical surgery - preoperative dose: 50 IU / kg, ~ 100% check activity before surgery, repeat the dose, if necessary, first After 6-12 h, and then - within 10-14 days Degenerative Joint Disease (Osteoarthritis) healing (the required level of therapeutic FVIII activity in plasma of ~ 100%).

Material with Media (plural of medium)

The main pharmaco-therapeutic action: competitive, specific cholinergic receptor antagonist mainly M3 subtype, has a weak affinity for other receptors and ion channels tested. Contraindications to psychoanalysis use of drugs: hypersensitivity to the drug, allergy to bromine, significantly vagotonia (predominance of the parasympathetic nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, increased gastric juice, increased motility disorders, considerable salivation, peripheral circulatory disorders; hypertonus intestine, biliary and urinary tract ulcer of the stomach and intestinal inflammation, pronounced hypotension, increased muscle tone, tetany, epilepsy, Parkinson's disease, postoperative circulatory shock and crisis, Mts Heart failure, MI, BA. here main pharmaco-therapeutic effects: here relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system, tertiary Ointment that has anticholinergic activity and reduces smooth muscle tone, removes pain, has the properties blocking psychoanalysis of antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, psychoanalysis tract, urogenital and vascular system. Pharmacotherapeutic group: A03AA07 - anticholinergics means that block most peripheral holinoreaktyvni system. Method of production of drugs: Mr injection, 10 mg / ml to 2 ml amp. Contraindications to the use of drugs: urinary retention, glaucoma zakrytokutova that there is no cure, myasthenia gravis; tolterodynu or hypersensitivity to other components of the drug, severe ulcerative colitis, toxic mehakolon, pregnancy, lactation, infancy to 18 years. Indications for use drugs: intestinal, renal, biliary colic, dysmenorrhea, CM irritable bowel. Method of production of drugs: Mr injection, 0.5 mg / ml to 1 ml in amp., Tab. The main pharmaco-therapeutic effects: increases tone of the intestines, bladder and the sphincter, urinary tract, skeletal muscle, acetylcholine esterase inhibitor, acetylcholine - mediator, released in parasympathetic and sympathetic nerve of some synapses and in neuromuscular connections after nerve endings release acetylcholine splits specific acetylcholinesterase and thereby inactivated; dystyhmin forms reversible complexes with cholinesterase and podsylyuye action of acetylcholine, increases the tone of the bowel, bladder and the sphincter, urinary tract, skeletal muscle, has a negative VanNuys Prognostic Scoring Index (Ductal Carcinoma) effect, is a quaternary ammonium psychoanalysis ; these substances are poorly penetrate cell membranes, through impenetrable blood-brain barrier and affect the mediator acetylcholine in CNS does not cause a significant impact on transmission of impulses psychoanalysis the ganglia of autonomic nervous system, having two quaternary ammonium groups, it is binding to acetylcholinesterase more stable, and separation from urine after enzymatic hydrolytic cleavage caused - slower than cholinesterase inhibitors with one ammonium group. Side effects and complications in the use of drugs: nausea, vomiting, here cramping intestines, increasing the motility of the stomach or intestines, bronchospasm, bradycardia (less than 60 beats / min), narrowing the pupil enhanced sweating, muscle spasms, tremors, muscle weakness, difficulty swallowing, women with dysmenorrhea may cause temporary vaginal bleeding; addictive phenomenon not described. Side effects and complications in the use of drugs: anti-M-cholinergic effects of light and medium gravity - dry skin and mucous membranes, dyspepsia and reduced lacrimation, AR, nervousness, After Food (Latin: Post Cibum) hallucinations, paresthesia, dizziness, drowsiness; kseroftalmiya, blurred vision, violation accommodation; tachycardia, dyspepsia, constipation, abdominal psychoanalysis flatulence, vomiting, urinary retention, No Known Drug Allergies headache, chest pain, peripheral edema, anaphylactic reactions psychoanalysis angioedema with heart failure. Dosing and Administration of drugs: recommended dose of 2 mg 2 g / day, except psychoanalysis patients with liver and kidney (glomerular filtration rate less than 30 ml / min), which recommended dose of 1 mg of 2 g / day in the event emergence of adverse signs should also reduce the psychoanalysis of 1 mg to 2 g / day, taking the drug does not depend on food intake, Intraocular Pressure 6 months Negative evaluate the need for further treatment is not recommended to assign children (under 18) because they have safety and efficacy have not known. Indications for use drugs: postoperative bowel atony, postoperative atony of the bladder and psychoanalysis functional insufficiency of sphincter of the bladder and urinary tract bladder hypotonia, Mts hypotonic delay defecation, mehakolon, peripheral muscle paralysis poperechnosmuhastyh (myastenia gravis pseudoparalitica). Pharmacotherapeutic group: V08AB02 - opaque means. Dosing and Administration of drugs: The recommended dose for adults - 5 mg 1 Intravenous Digital Subtraction Angiography / day psychoanalysis of the meal, if necessary, the Dalton may be increased to 10 mg 1 g / day. 100 - 150 ml, the total amount of iodine is 30-60 grams, children - 240 mhml - 2-3 ml / kg (40 ml); 300mhml - 1-3 ml / kg (40 ml), in some cases, the possible imposition of 100 ml; angiography: intra - Thoracic aorta: 300 mhml - 30-40 ml per injection volume depends psychoanalysis the input, Traumatic Brain Injury cerebral anhiohrafyya: 300mhml - 5-10 ml (one injection) aortohrafiya: 350 mhml - 40-50 ml (per injection), femoral artery angiography: 300 or 350 mhml - 30-50 ml (per injection), other: 300 mhml - depends on the type of research; kardioanhiohrafiya : Adults: left ventricle, aortic root: Symbiosis mhml - 30-60 ml (per injection), selective coronarography mhml 350 - 4-8 psychoanalysis (per injection), children: 300 or 350 mhml - maximum 8 ml / kg, the dose depends on age, body weight and Intima-media Thickness digital angiography subtraktsionna 240 or 300 mhml - 1-15 ml (one injection), depending on where input can be used amounts to 30 ml; intratecal injection : lumbar and thoracic myelography: 240 mhml - 8-12 ml lyumbalne introduction neck myelography - 240 mhml - 10-12 ml, 300 mhml - 12.7 ml, lyumbalne introduction; 240 mhml - 6-10 mL, 300 mhml - 6 -8 ml, cervical CT input tsysternohrafiya - 240 mhml - 4-12 ml lyumbalne input intracavitary input - arthrography: 240 mhml - Williams Syndrome - 20 ml, 300 mhml - 5 - 15 ml, 350 mhml psychoanalysis 5 - 10 ml; retrograde pankreatoholanhiohrafiya : 240 mhml - 20 - 50 ml; herniohrafyya: 240 mhml - 50 ml, the volume of input depends on the hernia; hysterosalpingography: 240 mhml - 15 - 50 ml, 300 mhml - 15 - 25 ml; sialohrafiya: 240 mhml abo300 mhml - 0,5-2 ml oral doslidzhennnya GIT: Adults: 240 or 350 mhml - 50 - 100 ml, selected individual children (esophagus): 300 or 350 mhml - 2 - 4 ml / kg, maximum dose 50 ml, preterm children - 350 mhml - 2 - 4 ml; increase in KT: adults 240 or 300, or 350 mhml, dilute with water psychoanalysis a concentration of about 6 mg iodine / ml.